XML 30 R6.htm IDEA: XBRL DOCUMENT v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Class A and Class B Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income/(Loss)
Accumulated Deficit
Non- Controlling Interest
Balances beginning (in shares) at Dec. 31, 2024   666,419        
Balance beginning at Dec. 31, 2024 $ 209,000 $ 0 [1] $ 4,221,000 $ (4,000) $ (3,995,000) $ (13,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of stock options (in shares)   14,358        
Issuance of common stock upon exercise of stock options 39,000   39,000      
Issuance of common stock under Employee Stock Purchase Plan (in shares)   1,011        
Issuance of common stock under Employee Stock Purchase Plan 24,000   24,000      
Vesting of restricted stock units and performance stock units (in shares)   11,373        
Stock-based compensation expense 544,000   544,000      
Other comprehensive income/(loss) 18,000     18,000    
Net loss (496,000)       (493,000) (3,000)
Balance ending (in shares) at Jun. 30, 2025   693,161        
Balance ending at Jun. 30, 2025 338,000 $ 0 [1] 4,828,000 14,000 (4,488,000) (16,000)
Balances beginning (in shares) at Mar. 31, 2025   677,750        
Balance beginning at Mar. 31, 2025 297,000 $ 0 [1] 4,516,000 5,000 (4,210,000) (14,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of stock options (in shares)   9,727        
Issuance of common stock upon exercise of stock options 27,000   27,000      
Vesting of restricted stock units and performance stock units (in shares)   5,684        
Stock-based compensation expense 285,000   285,000      
Other comprehensive income/(loss) 9,000     9,000    
Net loss (280,000)       (278,000) (2,000)
Balance ending (in shares) at Jun. 30, 2025   693,161        
Balance ending at Jun. 30, 2025 $ 338,000 $ 0 [1] 4,828,000 14,000 (4,488,000) (16,000)
Balances beginning (in shares) at Dec. 31, 2025 708,359 708,359        
Balance beginning at Dec. 31, 2025 $ 375,000 $ 0 [2] 5,438,000 17,000 (5,061,000) (19,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of stock options (in shares) 1,759 1,759        
Issuance of common stock upon exercise of stock options $ 7,000   7,000      
Issuance of common stock in connection with the acquisition of a business (in shares)   993        
Issuance of common stock from acquisition of a business 12,000   12,000      
Issuance of common stock under Employee Stock Purchase Plan (in shares)   524        
Issuance of common stock under Employee Stock Purchase Plan 27,000   27,000      
Vesting of restricted stock units and performance stock units (in shares)   10,886        
Repurchases and retirement of common stock (in shares)   (8,229)        
Repurchases and retirement of common stock (380,000)   (380,000)      
Stock-based compensation expense 557,000   557,000      
Other comprehensive income/(loss) (36,000)     (36,000)    
Net loss $ (433,000)       (429,000) (4,000)
Balance ending (in shares) at Jun. 30, 2026 714,292 714,292        
Balance ending at Jun. 30, 2026 $ 129,000 $ 0 [2] 5,661,000 (19,000) (5,490,000) (23,000)
Balances beginning (in shares) at Mar. 31, 2026   715,795        
Balance beginning at Mar. 31, 2026 411,000 $ 0 [2] 5,744,000 (5,000) (5,307,000) (21,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of stock options (in shares)   865        
Issuance of common stock upon exercise of stock options 3,000   3,000      
Issuance of common stock in connection with the acquisition of a business (in shares)   993        
Issuance of common stock from acquisition of a business 12,000   12,000      
Vesting of restricted stock units and performance stock units (in shares)   4,868        
Repurchases and retirement of common stock (in shares)   (8,229)        
Repurchases and retirement of common stock (380,000)   (380,000)      
Stock-based compensation expense 282,000   282,000      
Other comprehensive income/(loss) (14,000)     (14,000)    
Net loss $ (185,000)       (183,000) (2,000)
Balance ending (in shares) at Jun. 30, 2026 714,292 714,292        
Balance ending at Jun. 30, 2026 $ 129,000 $ 0 [2] $ 5,661,000 $ (19,000) $ (5,490,000) $ (23,000)
[1] Amounts in this column round to zero.
[2]
* Amounts in this column round to zero.